Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126172521	12617252	1	I	2005	20160324	20160803	20160803	EXP		US-UCBSA-2016011251	UCB		0.00			F	Y	0.00000		20160803		CN	US	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	DECHAL	RECHAL	LOT NUM	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126172521	12617252	1	PS	LACOSAMIDE.	LACOSAMIDE	1		UNK	Y	N		22253
126172521	12617252	2	SS	LACOSAMIDE.	LACOSAMIDE	1	Oral	150 MG, 2X/DAY (BID)	Y	N	119701	22253	150	MG		BID
126172521	12617252	3	SS	CLONAZEPAM.	CLONAZEPAM	1		UNK	Y	U		0			TABLET
126172521	12617252	4	SS	CLONAZEPAM.	CLONAZEPAM	1	Oral	0.5 MG, 2X/DAY (BID)	Y	U		0	.5	MG	TABLET	BID

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126172521	12617252	1	Seizure
126172521	12617252	3	Epilepsy

Outcome of event

Event ID	CASEID	OUTC COD
126172521	12617252	OT

Reactions reported

Event ID	CASEID	PT
126172521	12617252	Back pain
126172521	12617252	Complex partial seizures
126172521	12617252	Dyspnoea
126172521	12617252	Feeling abnormal
126172521	12617252	Gait disturbance
126172521	12617252	Nausea
126172521	12617252	Seizure
126172521	12617252	Tremor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT
126172521	12617252	1	2005
126172521	12617252	2	201203
126172521	12617252	4	201607